Ghent University Academic Bibliography

Your filters: cql: author="Mulders, Peter" or (type any "bookEditor issueEditor" and editor="Mulders, Peter")

Add to list
- Journal Article
- A1
- open access
[89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma : a prospective, open-label, multicentre, phase 3 trial

Brian Shuch, Allan J Pantuck, Jean-Christophe Bernhard, Michael A Morris, Viraj Master, Andrew M Scott, Charles Van Praet (UGent) , Clement Bailly, Bülent Önal, Tamer Aksoy, et al.

(2024) LANCET ONCOLOGY. 25(10). p.1277-1287
Add to list
Cytoreductive nephrectomy and exposure to sunitinib : a post hoc analysis of the immediate surgery or surgery after sunitinib malate in treating patients with metastatic kidney cancer (SURTIME) trial

Yasmin Abu‐Ghanem, Johannes V. Thienen, Christian Blank, Maureen J. B. Aarts, Michael Jewett, Igle Jan Jong, Jean‐Baptiste Lattouf, Harm H. E. Melick, Lori Wood, Peter Mulders, et al.

(2022) BJU INTERNATIONAL. 130(1). p.68-75
Add to list
Surgical safety of cytoreductive nephrectomy following sunitinib : results from the multicentre, randomised controlled trial of immediate versus deferred nephrectomy (SURTIME)

Roderick Emile De Bruijn, Peter Mulders, Michael A Jewett, John Wagstaff, Johan V Van Thienen, Christian U Blank, Roland Van Velthoven, Lori Wood, Harm E van Melick, Maureen J Aarts, et al.

(2019) EUROPEAN UROLOGY. 76(4). p.437-440
Add to list
Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib : the SURTIME randomized clinical trial

Axel Bex, Peter Mulders, Michael Jewett, John Wagstaff, Johannes V van Thienen, Christian U Blank, Roland van Velthoven, Maria del Pilar Laguna, Lori Wood, Harm HE van Melick, et al.

(2019) JAMA ONCOLOGY. 5(2). p.164-170
Add to list
Evaluation of two urinary RNA biomarker tests with an epigenetic DNA assay for the identification of men with high-grade prostate cancer

Geert Trooskens, Anglita Yantisetiasti, Rianne Hendriks, Inge Van Oort, Peter Mulders, Christina Hulsbergen-van de Kaa, Wim Van Criekinge (UGent) and Jack Schalken

(2018) JOURNAL OF UROLOGY. 199(4, suppl.). p.e610-e610

Academic Bibliography

[89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma : a prospective, open-label, multicentre, phase 3 trial

Cytoreductive nephrectomy and exposure to sunitinib : a post hoc analysis of the immediate surgery or surgery after sunitinib malate in treating patients with metastatic kidney cancer (SURTIME) trial

Surgical safety of cytoreductive nephrectomy following sunitinib : results from the multicentre, randomised controlled trial of immediate versus deferred nephrectomy (SURTIME)

Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib : the SURTIME randomized clinical trial

Evaluation of two urinary RNA biomarker tests with an epigenetic DNA assay for the identification of men with high-grade prostate cancer

Contents

Support

Contact